PR.com is a leader in paid and free press release distribution.
To reach journalists, increase online visibility, and attract new customers,
submit via our global online news and press release distribution service to
top search engines, thousands of websites, social media, blogger networks,
as well as via print, broadcast, radio, mobile channels, and more.
Experimentica Ltd. has been selected for Phase 1 of the Young Innovative Company program by Business Finland (formerly known as TEKES, The Finnish Funding Agency for Technology and Innovation). The funding awarded for the first phase is a 250,000 € grant for a period of 12 months.
“Every... - February 21, 2018 - Experimentica Ltd
Medical Evolutions 1 Inc. was established to educate the general public on becoming “empowered” in participating in their own healthcare along with their physician via the Medical Evolutions 1 Inc. Pharmacogenomic Comprehensive ME TEST™. The goal is to make the ordering and utilization of the test a simple, uncomplicated yet an effective process as well as making the test economically available to most. - February 21, 2018 - Medical Evolutions 1 Inc.
Perthera, Inc., the leading Therapeutics Intelligence Company™, has announced its partnership with Blue Faery, the leading Hepatocellular Carcinoma advocacy group in the US, with the goal to provide liver cancer patients with therapeutic treatment options precisely matched to their individual cancers.
“At... - February 20, 2018 - Perthera, Inc.
Apostle Inc is pleased to announce the appointment of Alexander J. Hartemink, PhD as a new member to its Scientific Advisory Board. Dr. Hartemink is Professor of Computer Science and Biology at Duke University. He is the faculty director of the Office of Undergraduate Scholars and Fellows and the active... - February 19, 2018 - Apostle Inc
Turnover has increased by 13% compared with 2016, staff has increased by 20%, 14% of investment in research and the launch of a new therapeutic solution: these are the figures of the year which has just ended for the company that has made laser therapy its flagship of excellence. The 2018 objective? Growth marked by internationalisation. - February 17, 2018 - ASA srl
Wellness Family Medicine in Spartanburg, South Carolina has been approved to accept TRICARE insurance. - February 13, 2018 - Wellness Family Medicine
Apostle Inc is pleased to announce the appointment of David B. Goldstein, PhD as a new member to its Scientific Advisory Board. Dr. Goldstein is John E. Borne Professor of Medical and Surgical Research at Columbia University. - February 11, 2018 - Apostle Inc
With highly qualified sales and support staff covering both Canada and the United States and extensive expertise in supplying the life sciences with novel and high quality scientific instrumentation, Scintica is perfectly placed to partner with Oxford Optronix.
The Scintica team consists of scientists,... - February 07, 2018 - Scintica Instrumentation
Latest innovation in cryostorage planning expand options for reproductive tissue disposition. - February 01, 2018 - ReproTech, Ltd.
Mopec, an industry leading manufacturer and distributor of high quality pathology, anatomy, mortuary, and necropsy equipment and products, is pleased to announce the addition of Sally Brandtneris and Dr. Joyce deJong to the Company’s Board of Directors. - January 31, 2018 - Mopec
NanoHybrids, announces the launch of PAtrace, a proprietary nanoparticle that provides high resolution visualization and verification of the enhanced permeability and retention (EPR) effect in heterogeneous tumor models. PAtrace is being launched at the 2018 SPIE BioS Expo. - January 29, 2018 - NanoHybrids
Eagle Biosciences, Inc. is proud to announce the launch of a new assay, MedFrontier FGF23 (Human Intact FGF23) ELISA Assay Kit. MedFrontier FGF23 (Human Intact FGF23) ELISA Assay Kit utilizes a simple 96 well sandwich ELISA procedure that measures ONLY the full-length active form (intact form) in under three hours. - January 26, 2018 - Eagle Biosciences, Inc.
Wake Research Welcomes Christine Heironimus as New Director of Business Development and Strategic Network Acceleration. - January 25, 2018 - Wake Research Associates
The European Commission has adopted the following on 8 January 2018: Adoption of Commission Implementing Decision granting marketing authorisation under Regulation (EC) No 726/2004 of the European Parliament and of the Council for "Intrarosa - Prasterone," a medicinal product for human use. - January 15, 2018 - Endoceutics
Video Bytes are 1-minute summaries of published research that help scientists convey the importance of their work to the public. - January 12, 2018 - Research Square
A patient’s cornea can be altered in a simple manner designed to correct myopia and other refractive errors. The Nature Journal Eye published in print the complete article by Antonio Medina as well as supplemental files that will aid those interested in using this new technology. The article is featured on the cover of the issue and titled, Plastic modification of the cornea by pneumatic force corrects myopia: Pneumatic Keratology Eye (2017) 31, 1621–1627 - December 31, 2017 - Antonio Medina
SARI is a Chinese market-leader biotech investment company. - December 30, 2017 - NMS Group
A new year and a new event looking beyond the new – Nimbus Research Centre, in collaboration with SteriTrack, are proud to host a ground-breaking event for 2018 “Beyond the Internet of Things – How to harness the next wave of digital technology and investment” at Cork’s... - December 26, 2017 - Matrix Medical Tracking Systems
Siva Therapeutics in partnership with NanoHybrids have teamed to develop and manufacture gold nanoparticles for treating cancer with hyperthermia. The nanoparticle treatment was submitted to the Frederick National Laboratory for Cancer Research and has passed the first stages in the Nanotechnology Characterization Laboratory, which helps pave the way for regulatory review of nanotechnologies intended for cancer therapies and diagnostics. - December 15, 2017 - NanoHybrids
NanoHybrids Inc. has been awarded $300,000 by the National Cancer Institute of the National Institutes of Health (NIH) through the Small Business Technology Transfer (STTR) program to enhance the therapeutic efficacy of photodynamic therapy (PDT) in oral cancers. - December 15, 2017 - NanoHybrids
A presentation at the Southwestern Association of Toxicologists November 2017 scientific meeting in San Antonio, Texas highlighted the utility of Cayman’s Synthetic Cannabinoid Screening Library. This library is comprised of more than 350 synthetic cannabinoid standards, including parent compounds... - December 14, 2017 - Cayman Chemical Company
The International Society on Thrombosis and Haemostasis (ISTH) today announced that the city of London has been selected as the location for the ISTH 2022 Congress. The official meeting dates will be announced in early 2018.
“On behalf of the thrombosis and haemostasis community in the United... - December 13, 2017 - International Society on Thrombosis and Haemostasis (ISTH)
Blue Diesel Data Science announces the beta launch of its pharmaceutical platform VisionaryRX. VisionaryRX provides a deep and comprehensive view into the drug industry. It relates multiple forms of industry standard data in the pharmaceutical industry under one view. Because VisionaryRX uses over 50 million rows of information, the result is fast and complete visibility into the industry. Useful for pharmaceutical manufacturing, labeling, partnerships and strategic direction insight. - December 10, 2017 - Blue Diesel Data Science
GeneFluidics, a molecular diagnostics company specializing in the development of diagnostics solutions for infectious diseases, today announced CE marking for UtiMax™ under the Directive 98/79/EC on in vitro diagnostic medical devices. UtiMax™has successfully completed a multicenter validation study and clinical testing. It does not require clinical isolates from urine cultures, enabling a rapid ID reporting in as short as 30 minutes and AST in 120 minutes for a positive ID result. - December 10, 2017 - GeneFluidics Inc.
On January 24, 2018, NJCTS will celebrate the 10th Anniversary milestone with a special webinar geared towards school nurses. - December 07, 2017 - New Jersey Center for Tourette Syndrome
Health Test Express Makes At-Home Health Testing Available - December 02, 2017 - Analyte Health
Perthera, Inc., the leading Therapeutics Intelligence Company™, has announced its partnership with ZERO, the leading nonprofit prostate cancer advocacy group in the USA, to form and launch the nationwide Decode Your Prostate Cancer program aimed to provide each prostate cancer patient with therapeutic... - November 28, 2017 - Perthera, Inc.
Mopec introduces new cadaver lift series that feature more versatility in design and performance. Created with the consumer in mind, each lift has an adjustable top with a simple structure, achieving a Mopec standard in efficiency. An enhanced mechanical system offers advanced technological features... - November 24, 2017 - Mopec
End of year fundraiser to further innovative breast cancer research. - November 22, 2017 - Dr. Susan Love Research Foundation
Dr. Early, a physician with Wellness Family Medicine has been credentialed by TRICARE Insurance. - November 22, 2017 - Wellness Family Medicine
Nurse Betty has been approved as a provider for United Healthcare. - November 22, 2017 - Wellness Family Medicine
Gordon Early, MD with Wellness Family Medicine receives approval as a Medicaid provider. - November 20, 2017 - Wellness Family Medicine
Ira Gordon Early Jr., MD, MPH is now part of the Cigna Insurance Network. - November 19, 2017 - Wellness Family Medicine
Dr. Gordon Early has been accepted to provide services for Aetna. - November 19, 2017 - Wellness Family Medicine
Dr. Ira Gordon Early has been approved to offer services as part of the Select Health of SC Insurance program (First Choice) - November 19, 2017 - Wellness Family Medicine
Gordon Early, MD, MPH, FACOEM, physician with Wellness Family Medicine was approved as a provider with Wellcare. - November 19, 2017 - Wellness Family Medicine
The Asia Microbiota Bank, the first stool bank in Hong Kong, expands the team by adding a new scientist to help lead research efforts on bacteria clusters unique to the Asian population. The scientific team uses next generation sequencing and strain level analysis to optimize Fecal Microbiota Transplantation (FMT) treatment outcomes in Asia. "We hope that the deep FMT data we are collecting from around Asia will help uncover key strains that influence intestinal health."-Co-Founder, Jon Chan - November 16, 2017 - Asia Microbiota Bank
Endoceutics Inc., a private Quebec City based biopharma company, today announced that the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product IntrarosaTM, intended for the treatment of vulvar... - November 13, 2017 - Endoceutics
Dr. Gordon Early has been approved with United Healthcare. - November 06, 2017 - Wellness Family Medicine
Innovative Newborn Screening and Pediatric Testing Company Ships 2 Millionth Test - October 31, 2017 - Baebies, Inc.
Clinerion has expanded its geographic coverage to include over 60 million patients in the USA, via a strategic partnership with Provisio Inc. Clinerion now has a truly global footprint for its services for clinical trial patient search and identification, and data generation for real-world evidence and market access activities. - October 30, 2017 - Clinerion
NASA’s James Webb Space Telescope, the replacement to the Hubble Space Telescope is Now Hanging Out in a Vibration-Isolating "Hammock" Supported by Minus K's Negative-Stiffness Vibration Isolators in Johnson Space Center's Vaccum Chamber A being tested. - October 28, 2017 - Minus K Technology Inc.
Multiplex assays have been plagued by a lack of specificity and accuracy, with unreliable data as a result. However, a new multiplex assay has reached the US market. Mercodia, based in Sweden, has teamed-up with Quansys Biosciences, based in the US, to launch the AKURIO Islet Hormones multiplex assay, which measures four of the most notable hormones in pancreatic research: glucagon, insulin, C‑peptide and proinsulin. - October 27, 2017 - Mercodia AB
The Morgan Leary Vaughan Fund (Morgan’s Fund) recently received a $4,000.00 grant from The Petit Family Foundation in support of the inaugural “Speaking of NEC: Unplugged” event, a one-day regional conference focused on identifying practical solutions for reducing the devastating effects... - October 16, 2017 - The Morgan Leary Vaughan Fund, Inc.
ClinLab Staffing (www.clinlabstaffing.com), ranked among the fastest-growing private companies in Massachusetts by the Boston Business Journal, moved to its new headquarters at the Riverworks Innovation Center in the Charles River Mill District of Watertown Massachusetts, effectively doubling its workspace... - October 12, 2017 - ClinLab Staffing
Adds to Strategic Partnerships across Western and Southern United States - October 04, 2017 - Wake Research Associates
Mapp Biopharmaceutical, Inc., announced today that it has been awarded a Project BioShield contract (HHSO100201700017C) of approximately $46 million by The Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the... - September 30, 2017 - Mapp Biopharmaceutical, Inc.
A new cancer treatment with the dual ability to normalise tumour blood vessels and boost the body’s immune system, has been developed by researchers from the Harry Perkins Institute of Medical Research and The University of Western Australia. - September 28, 2017 - Harry Perkins Institute of Medical Research
The Morgan Leary Vaughan Fund (Morgan’s Fund) is pleased to announce that it has received an award from Graphic Design USA (GDUSA). The "Speaking of NEC" brochure, created as a companion piece to the audio podcast series of the same name, has been recognized as part of GDUSA’s 2017... - September 27, 2017 - The Morgan Leary Vaughan Fund, Inc.
Perthera Inc.’s, Subha Madhavan, PhD, Chief Bioinformatics Officer, will be speaking at the 11th Annual Fall Conference of Health 2.0 on Healthcare Innovations, Oct 1 - 4 in Santa Clara, CA, in the Personalized Health Track “Turning Data into Value.”
Dr. Madhavan will present a key... - September 26, 2017 - Perthera, Inc.